Hodgkin's disease

Acta Oncologica

Volumn 35, Issue SUPPL. 7, 1996, Pages 93-101

  Gustafsson, Anita ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; HODGKIN DISEASE; HUMAN; META ANALYSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; RADIOTHERAPY;

COMBINED MODALITY THERAPY; HODGKIN DISEASE; HUMANS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 0030323237     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841869609101669     Document Type: Article

References (104)

1. Longo D, Duffey P, Hubbard S, Young R, DeVita V. Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast. J Clin Oncol 1992; 10: 1367-9. (O2)
2. Henry-Amar M, Somers R. Survival outcome after Hodgkin's disease: A report from the international data base on Hodgkin's disease. Semin Oncol 1990; 17: 758-68. (R1/14 225)
3. Tubiana M, Henry-Amar M. Carde P, et al. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 1989; 73: 47-56. (C1/l 579)
4. Bonfante V, Santoro A. Viviani S, et al. Early stage Hodgkin's disease: Ten-year results of a non-randomized study with radiotherapy alone or combined with MOPP, Eur J Cancer 1993; 29A: 24-9. (P2/201)
5. Carde P, Burgers J, Henry-Amar M, et al. Clinical stages I and II Hodgkin's disease: A specifically tailored therapy according to prognostic factors. J Clin Oncol 1988; 6: 239-52. (C1/494) (Pubitemid 18068598)
6. Mandelli F, Anselmo A. Cartoni C, Cimino G, Maurizi Enrici R, Biagini C, Evaluation of therapeutic modalities in the control of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1986: 12: 1617-20. (R3/58) (Pubitemid 17175248)
7. Lee C, Aeppli D, Bloomfield C, Levitt S, Curative radiotherapy for laparatomy-staged IA, IIA, IIlA Hodgkin's disease: An evaluation of the gains achieved with radical radiotherapy. Int J Radiat Oncol Biol Phys 1990; 19: 547-59. (P2/179) (Pubitemid 20324246)
8. Gospodarowicz M. Sutcliffe S, Bergsagel D, Chua T. Radiation therapy in clinical stage I and I1 Hodgkin's disease. Eur J Cancer 1992; 28A: 1841-6. (R1/731)
9. Roach M. Brophy N. Cox R, Varghese A. Hoppe R. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease. J Clin Oncol 1990; 8: 673-9. ( R1/ 109)
10. Healey E. Tarbell N. Kalish L. et al. Prognostic factors for patients with Hodgkin disease in first relapse. Cancer 1993; 71: 2613 20. (R1/627)
11. Hartsell W, Sarin P, Recine D. et al. Long-term results of curative irradiation in pathologically staged 1A and 11A Hodgkin's disease. Radiol 1993; I85: 565-8. (R1/176) (Pubitemid 23033891)
12. Wasserman T, Trenkner D. Fineberg B. Kucik N. Cure of early-stage Hodgkin's disease with subtotal nodal irradiation. Cancer 1991; 68: 1208-15. (R2/94)
13. Mauch P, Tarbell N, Weinstein H, et al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 1988; 6: 1576-83. (R1/315) (Pubitemid 19092393)
14. Vinciguerra V, Propert K, Coleman M, et al. Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospective randomized study by the cancer and leukemia Group B. J Clin Oncol 1986; 4: 838-46. (C2/113) (Pubitemid 16080936)
15. Hoppe R. Radiation therapy in the management of Hodgkin's disease. Semin Oncol 1990; 17: 704-15. (L1)
16. Haybittle J, Easterling M. Bennett M, et al. Review of British national lymphoma investigation studies of Hodgkin's disease and development of prognostic index. Lancet 1985; April 27: 967-72. (C1/743) (Pubitemid 15123968)
17. Rosenberg S, Kaplan H. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. Int J Radiat Oncol Biol Phys 1985; 11: 5-22. (C2/835)
18. Shore T. Nelson N, Weinerman B. A meta-analysis of stages I and II Hodgkin's disease. Cancer 1990; 65: 1155-60. (M2/2 999)) (Pubitemid 20072051)
19. Radiotherapy of stage I and II Hodgkin's disease. A collaborative study. Cancer 1984; 54: 1928-42. (C1/460)
20. Farah R. Ultmann J, Griem M, et al. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol 1988; 6: 1047-52. (R2/135)
21. Mendenhall N, Taylor B. Marcus R. Million R. The impact of pelvic recurrence and elective pelvic irradiation on survival and treatment morbidity in early-stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1991; 21: 1157-65. (R3/153)
22. Cosset M, Henry-Amar M, Meerwaldt J, et al. The EORTC trials for limited stage Hodgkin's disease. Eur J Cancer 1992: 28A: 1847-50. (C1/1641)
23. Ganesan T, Wrigley P, Murray P, et al. Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital. Br J Cancer 1990; 62: 314-8. (R2/90) (Pubitemid 20242460)
24. Anderson H. Deakin D, Wagstaff J, et al. A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: A report from the Manchester Lymphoma Group, Br J Cancer 1984: 49: 695-702. (C2/114) (Pubitemid 14113725)
25. Andrieu J-M, Dana M, Desprez-Curely J-P, Jacquillat C. Weil M. MOPP chemotherapy plus irradiation for Hodgkin's disease. stages IA to IIIB. Long-term results of the prospective trial H72 (1972-1976, 334 patients). Heniatol Oncol 1985: 3: 219-31. (P2/334)) (Pubitemid 16197676)
26. Crnkovich M. Hoppe R, Rosenberg S, Stage IIB Hodgkin's disease: The Stanford experience. J Clin Oncol 1986; 4: 472-9. (R3/126) (Pubitemid 16117935)
27. Zittoun R. Audebert A. Hoerni B, et al. Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. J Clin Oncol 1985; 3: 207-14. (C2/335) (Pubitemid 15153762)
28. Biti G, Cimino G. Cartoni C, et al. Extended-field radiothcrapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight-year update of an Italian prospective randomized study. J Clin Oncol 1992; 10: 378-82. (C2/89)
29. Cimino G. Biti G, Cartoni C, Magrini S, Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: Evidence of a more difficult rescue for patients relapsed alter chemotherapy. Eur J Cancer 1992; 28A: 1853- 5. (C2/89)
30. Longo D, Glatstein E. Duffey P, et al. Radiation therapy versus combination chemotherapy in the treatment of earlystage Hodgkin's disease: Seven-year results of a prospective randomized trial. J Clin Oncol 1991: 9: 906-17. (C2/87)
31. Anselmo A, Bove M. Cartoni C, et al. Combined modality ( ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement. Haematol 1992: 77: 177-9.(C3/73)
32. Straus D, Yahalom J, Gaynor J, et at. Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease. Cancer 1992; 69: 1052-60. (C2/l20)
33. Nordentoft A, Nissen N. Bjørn Jensen K. Experiences from the national Danish Hodgkin's study Group (LYGRA) with respect to diagnosis. classification and treatment of Hodgkin's disease. Acta Radiol Oncol 1984: 23: 163 7. (C1/310) (Pubitemid 14113540)
34. Specht L, Carde P, Mauch P, Magrini S, Santarelli M. Radiotherapy versus combined modality in early stages. Ann Oncol 1992; 3 (Suppl 4): 77-81. (M2/2069)
35. Horning S, Hoppe R. Hancock S, Rosenberg S, Vinblastine bleomycin, and methotrexate: An effective adjuvant in favorable Hodgkin's disease. J Clin Oncol 1988; 6: 1822 31. (C3/67) (Pubitemid 19089064)
36. Pavlovsky S, Maschio M. Santarelli M. et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage 1-11 Hodgkin's disease. J Natl Cancer Inst 1988; 80: 1466-73. (C2/277) (Pubitemid 18264890)
37. Bessel E. MacLennan K. Toghill P, Ellis I. Fletcher J, Dowling F. Suprahyoid Hodgkin's disease stage IA. Radiother Oncol 1991; 22: 190-4. (R2/71)
38. Gospodarowicz M. Sutcliffe S, Clark R, et al. Analysis of supradiaphragmatic clinical stage I and I I Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys 1992; 22: 859-65. (R1/250)
39. Urba W, Longo D. Hodgkin's disease. N Engl J Med 1992; 326: 678-87. (L1)
40. Levitt S, Lee C, Aeppli D. Lindgren B. Peterson B. The role of radiation therapy in Hodgkin disease: Experience and controversy. The 54th annual Janeway lecture: 1989. Cancer 1992; 70: 693-703. (P2/179)
41. Tarbell N. Thompson L. Mauch P, Thoracic irradiation in Hodgkin's disease: Disease control and long-term complications. Int J Radiat Oncol Biol Phys 1990; 18: 275 81.(R1/590) (Pubitemid 20097519)
42. Orlandi E, Lazzarino M. Brusamolino E. et al. Residual mediastinal widening following therapy in Hodgkin's disease. Hematol Oncol 1990: 8: 125-31. (R2/102) (Pubitemid 20298876)
43. Radford J, Cowan R. Flanagan M. et al. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 1988; 6: 940-6. (R2/l10)
44. Leopold K, Canellos G. Rosenthal D. Shulman L. Weinstein H, Mauch P, Stage IA - llB Hodgkin's disease: Staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol 1989: 7: 1059-65. (R2/92) (Pubitemid 19196528)
45. Zinzani P, Maim P, Gherlinzoni F. et al. Massive mediastinal involvement in stage 1-11 Hodgkin's disease: Response to combined modality treatment. Leuk Lymph 1992: 8: 81-5. (P2/37)
46. Longo D. Russo A. Duffey P, et al. Treatment of advancedstage massive mediastinal Hodgkin's disease: The case for combined modality treatment. J Clin Oncol 1991: 9: 227 35. (R3/49)
47. Dowling S, Peschel R, Portlock C, Kramer C, Farber L, Knowlton A. Mediastinal irradiation in combined modality therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1990; 19: 543-6. (R3/50) (Pubitemid 20324245)
48. Chen J, Osborne B. Butler J, Residual fibrous masses in treated Hodgkin's disease. Cancer 1987; 60: 407- 13. (R3/5) (Pubitemid 17098609)
49. Hoppe R. The management of stage II Hodgkin's disease with a large mediastinal mass: A prospective program emphasizing irradiation. Int J Radiat Oncol Biol Phys 1985; 11: 349-55. (R3/13) (Pubitemid 15137918)
50. Givens S, Fuller L. Hagemeister F, Gehan E. Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant Mechlorethamine, Vincristine, Procarbazine, and Prednisone. Cancer 1990; 66: 69-74. (R2/60) (Pubitemid 20197087)
51. Krikorian J, Portlock C, Mauch P, Hodgkin's disease presenting below the diaphragm: A review. J Clin Oncol 1986; 4: 1551 62. (L2) (Pubitemid 17183581)
52. Mauch P. Greenberg H. Lewin A. Cassady R. Weichselbaum R, Hellman S. Prognostic factors in patients with subdiaphragmatic Hodgkin's disease. Hematol Oncol 1983; 1: 205-14. (R3/36) (Pubitemid 13024676)
53. Mason M, Law M. Ashley S, et al. Infradiaphragmatic Hodgkin's disease. Eur J Cancer 1992; 28A: I851 -2. (R3/53)
54. Frassica D, Schomberg P, Banks P, Colgan J, Ilstrup D, Earle J, Management of subdiaphragmatic early-stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1989; 16: 1459-63. (R3/26) (Pubitemid 19154330)
55. Hou-Wun Mai D, Peschel R, Portlock C, Knowlton A, Farber L. Stage I and II subdiaphragmatic Hodgkin's disease. Cancer 1991; 68: 1476-81. (R3/19)
56. Leibenhaut M. Hoppe R, Varghese A, Rosenberg S, Subdiaphragmatic Hodgkin's disease: Laparotomy and treatment results in 49 patients. J Clin Oncol 1987; 5: 1050-5. (R2/49) (Pubitemid 18056011)
57. Mauch P, Goffman T, Rosenthal D, Canellos G, Come S, Hellman S, Stage III Hodgkin's disease: Improved survival with combined modality therapy as compared with radiation therapy alone. J Clin Oncol 1985; 3: 1166-73. (R2/120) (Pubitemid 15226520)
58. Prosnitz L. Cooper D, Cox E. Kapp D, Farber L. Treatment selection for stage IllA Hodgkin's disease patients. Int J Radiat Oncol Biol Phys 1985; 11: 1431-7. (R2/85) (Pubitemid 15033568)
59. Brada M, Ashley S, Nicholls J, et al. Stage III Hodgkin's disease-long term results following chemotherapy. radiotherapy and combined modality therapy. Radiother Oncol 1989; 14: 185-98. (R2/215) (Pubitemid 19087085)
60. Stein R, Golomb H, Wiernik P, et al. Anatomic substages of stage IIIA Hodgkin's disease: Followup of a collaborative study. Cancer Treat Rep 1982; 66: 733-41. (R2/130) (Pubitemid 12129358)
61. Oza A. Leahy M, Lim J, et al. The treatment of stage IIIA Hodgkin's disease- total nodal irradiation versus combination chemotherapy: Either or neither. J Clin Oncol 1991; 9: 1514-6. (R2/85)
62. Horning S, Ang P, Hoppe R, Rosenberg S, The Stanford experience with combined procarbazine. Alkeran and vinblastine ( PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease. Ann Oncol 1992; 3: 747-54. (R2/117)
63. Willett C, Linggood R, Meyer J, et al. Results of treatment of stage 3A Hodgkin's disease. Cancer 1987; 59: 27-30. (R3/38) (Pubitemid 17227390)
64. Henkelmann G. Hagemeister F, Fuller L. Two cycles of MOPP and radiotherapy for stage IlIlA and stage IIIlB Hodgkin's disease. J Clin Oncol 1988; 6: 1293-1301. (R2/76)
65. Crowther D, Wagstaff J, Deakin D, et al. A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IllA Hodgkin's disease. J Clin Oncol 1984: 2: 892-7. (C2/56) (Pubitemid 14037766)
66. Oza A. Ganesan T. Dorreen M, et al. Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years. Br J Cancer 1992; 65: 429-37. ( R I / 164)
67. Meerwaldt J, Coleman C, Fischer R, Lister T, Diehl V. Role of additional radiotherapy in advanced stages of Hodgkin's disease. Ann Oncol 1992; 3 (Suppl 4): 83-5. (Ll)
68. Hancock B, Vaughan Hudson G, Vaughan Hudson B, et al. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease-long term results. Br J Cancer 1991; 63: 579 82. (C1/290)
69. Sutcliffe S, Role of radiation therapy in advanced Hodgkin's disease-as yet, an answer? Still a question? Ann Oncol 1992; 3: 499-501. (O1)
70. Brizel D. Winer E. Prosnitz L, et al. Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. Int J Radiat Oncol Biol Phys 1990; 19: 535-42. (R2/154) (Pubitemid 20324244)
71. Santoro A, Bonadonna G. Valagussa P, et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 1987; 5: 27-37. (C1/232) (Pubitemid 17007853)
72. Prosnitz L. Farber L. Kapp D. et al. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data. J Clin Oncol 1988; 6: 603-12. (R2/184)
73. Yahalom J, Ryu J, Straus D, et al. Impact of adjuvant radiation of the patterns and rate of relapse in advancedstage Hodgkin's disease treated with alternating chemotherapy combinations. J Clin Oncol 1991; 9: 2193-2201.( R2/222)
74. Yelle L, Bergsagel D. Basco V, et al. Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial. J Clin Oncol 1991; 9: 1983-93. (C2/226)
75. Pavlovsky S, Santarelli M, Sackman Muriel F, et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III IV A & B Hodgkin's disease. Ann Oncol 1992: 3: 533-7. (C3/151)
76. Klimo P, Connors J, An update of the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPPiABV hybrid program. Semin Hematol 1988; 2 (Suppl 2): 34-40. (R2/79)
77. Roach M. Kapp D. Rosenberg S, Hoppe R. Radiotherapy with curative intent: An option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease. J Clin Oncol 1987; 5: 550-5. (R3/13) (Pubitemid 17062491)
78. Hoppe R. The management of Hodgkin's disease in relapse after primary radiation therapy. Eur J Cancer 1992; 28A: 1920-2. (R1/109)
79. Longo D, Duffey P, Young R, et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: The low probability for cure. J Clin Oncol 1992; 10: 210-8. (R2/107)
80. Viviani S, Santoro A, Negretti E. Bonfante V. Valagussa P. Bonadonna G. Salvage chemotherapy in Hodgkin's disease. Ann Oncol 1990; 1: 123-7. (R2/49)
81. Mauch P, Tarbell N, Skarin A. Rosenthal D, Weinstein H. Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. J Clin Oncol 1987; 5: 544-9. (R3/12) (Pubitemid 17062490)
82. Fox K. Lippman S, Cassady R, Heusinkveld R, Miller T. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. J Clin Oncol 1987; 5: 38 45. (R3/l7)
83. Leigh B, Fox K, Mack C, Baier M, Miller T, Cassady R. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 1993: 27: 855-62. (R3/26) (Pubitemid 23340297)
84. Kirkove C, Timothy A. Radiotherapy as salvage treatment in patients with Hodgkin's disease of non-Hodgkin's lymphoma relapsing after initial chemotherapy. Hematol Oncol 1991; 9: 163-7. (R3/6)
85. Diehl L, Perry D, Terebelo H, et al. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine)chemotherapy. Cancer Treat Rep 1983: 67: 827-9. (R3/6) (Pubitemid 13007289)
86. Salvagno L, Soraru M, Aversa S, et al. Late relapses in Hodgkin's disease: Outcome of patients relapsing more than twelve months after primary chemotherapy. Ann Oncol 1993; 4: 657-62. (R2/40) (Pubitemid 23291811)
87. Brada M, Eeles R. Ashley S, Nichols J, Horwich A. Salvage radiotherapy in recurrent Hodgkin's disease. Ann Oncol 1992; 3: 131-5. (R3/44)
88. Armitage JO. Early bone marrow transplantation in Hodgkin's disease. Ann Oncol 1994: 5 (Suppl 2): I6I - 3. (L1) (Pubitemid 24061341)
89. DeVita V. Hellman S, Jaffe E. Hodgkin's diseasc. Cancer: principles & practice of oncology 1993; 1819-58. (L1)
90. Sebag-Montefiore D. Maher E. Young J, Vaughan Hudson G. Hanks G. Variation in mantle technique: implications for establishing priorities for quality assurance in clinical trials. Radiother Oncol 1992; 23: 144-9. (O1)
91. Krueck W, Hess C, Kortmann R. Bamberg M. Simultaneous supra- and infradiaphragmatic irradiation in Hodgkin's disease. Brit J Radiol 1993; 66: 703-10. (R2/68) (Pubitemid 23244589)
92. Kaplan H. Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res 1966; 26: 1221 -4. (O1)
93. Fletcher G. Textbook of radiotherapy. 3rd ed. Chapter 7: The lymphomatous diseases. Philadelphia: Lea & Febiger. 1978. (Ll)
94. Vijayakumar S, Myrianthopoulos L. An updated dose-response analysis in Hodgkin's disease. Radiother Oncol 1992: 24: 1-13. (O1)
95. Hanks G, Kinzie J, White R. Herring D. Kramer S, Patterns of care outcome studies. Results of the national practice in Hodgkin's disease. Cancer 1983: 5 1 : 569 73. ( R 1 /407) (Pubitemid 13137667)
96. Schewe K, Reavis J, Kun L. Cox J, Total dose fraction size. and tumor volume in the local control of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1988: 15: 25 - 8. ( R2/112)
97. Schewe K, Kun L. Cox J, A step toward ending the controversies in Hodgkin's disease. Int J Radiat Oncol Biol Phys 1989; 17: 1123-4. (O2)
98. Raubitschek A. Glatstein E. The never-ending controversies in Hodgkin's disease. Int J Radiat Oncol Biol Phys 1989: 17: 1115-7. (O2)
99. Prosnitz L. Hodgkin's disease: The right dose. Int J Radiat Oncol Biol Phys 1990: 19: 803 -4. (O1) (Pubitemid 20324281)
100. Cosset J, Henry-Amar M. Meerwaldt J, Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience. Ann Oncol 1991 : 2 ( Suppl 2): 77 82. (RI/1 660)
101. Cosset J, Henry-Amar M. Girinski T. Malaise E. Dupouy N. Dutreix J, Late toxicity of radiotherapy in Hodgkin's disease. Acta Oncol 1988; 27: 173-9. (R1/140)
102. Henry-Amar M. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease. NC1 Monogr 1988: 6: 65-72. (RI/1 084) (Pubitemid 18047966)
103. Fletcher G, Shukovsky L. The interpaly of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol 1975; 56: 383 -400. (O1)
104. Landberg T. Liden K. Forslo H. Split-course radiation therapy of mediastinal Hodgkin's disease. TSD and CRE concepts. Acta Radiol 1973: 12: 33-9. (O2)